Local Application of the TLR-9 Agonist Dims0150 in Moderately Severe Ulcerative Colitis Patients
Phase of Trial: Phase III
Latest Information Update: 16 Oct 2013
At a glance
- Drugs Cobitolimod (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 16 Oct 2013 Results reporting changes from baseline in Disease Activity Index subscale scores presented at the 21st United European Gastroenterology Week.
- 05 Jun 2013 New trial record
- 18 May 2013 Results of a biomarker analysis presented at the Digestive Disease Week 2013.